Fmr LLC Siga Technologies Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Fmr LLC holds 38,778 shares of SIGA stock, worth $295,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,778

Previous 2,661 1357.27%

Holding current value

$295,876

Previous $22,000 1236.36%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.32 - $10.46 $228,259 - $377,783	36,117 Added 1357.27%	38,778 $294,000
Q1 2024 May 13, 2024	SELL	$4.51 - $8.92 $7,333 - $14,503	-1,626 Reduced 37.93%	2,661 $22,000
Q4 2023 Feb 13, 2024	BUY	$4.82 - $6.25 $5,567 - $7,218	1,155 Added 36.88%	4,287 $24,000
Q3 2023 Nov 13, 2023	BUY	$4.32 - $5.77 $6,423 - $8,579	1,487 Added 90.4%	3,132 $16,000
Q2 2023 Aug 11, 2023	BUY	$5.0 - $6.31 $1,120 - $1,413	224 Added 15.76%	1,645 $8,000
Q1 2023 May 11, 2023	BUY	$5.23 - $8.42 $2,850 - $4,588	545 Added 62.21%	1,421 $8,000
Q4 2022 Feb 13, 2023	SELL	$7.29 - $10.14 $335 - $466	-46 Reduced 4.99%	876 $6,000
Q3 2022 Nov 10, 2022	BUY	$10.02 - $26.15 $771 - $2,013	77 Added 9.11%	922 $10,000
Q2 2022 Aug 12, 2022	BUY	$6.5 - $13.68 $916 - $1,928	141 Added 20.03%	845 $10,000
Q1 2022 May 13, 2022	BUY	$5.96 - $7.61 $1,287 - $1,643	216 Added 44.26%	704 $5,000
Q4 2021 Feb 14, 2022	BUY	$6.96 - $9.26 $438 - $583	63 Added 14.82%	488 $3,000
Q3 2021 Nov 15, 2021	SELL	$5.71 - $7.39 $5 - $7	-1 Reduced 0.23%	425 $3,000
Q2 2021 Aug 13, 2021	BUY	$6.1 - $7.58 $2,598 - $3,229	426 New	426 $2,000

Others Institutions Holding SIGA

# of Institutions

171

Shares Held

34.2M

Call Options Held

353K

Put Options Held

843K

View Full List

About SIGA TECHNOLOGIES INC

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $557M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

More about SIGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account